{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P12107",
      "entity_text" : "COL11A1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0160" ],
      "Organ" : [ "uberon:UBERON:0000479" ],
      "CellType" : [ "cl:CL:0000499" ]
    }
  },
  "verbose_text" : "COL11A1 promotes tumor progression and predicts poor clinical outcomes in ovarian cancer, with the 5-year overall survival and recurrence-free survival rates being markedly lower in patients with high tissue expression levels of COL11A1, compared with those with low expression levels.",
  "reading_complete" : "2020-08-02T16:20:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:19:42Z",
  "trigger" : "levels",
  "evidence" : [ "levels of COL11A1" ],
  "pmc_id" : "5810222",
  "score" : 0
}